PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsTelix
Telix
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
IlluccixGallium ga gozetotide2021-12-17
Positron-emission tomography
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Girentuximab
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
,
urologic neoplasms
,
transitional cell carcinoma
,
recurrence
,
clear cell adenocarcinoma
,
adenomyoepithelioma
,
neoplasms
,
hepatocellular carcinoma
,
cholangiocarcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
colorectal neoplasms
,
pancreatic ductal carcinoma
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
esophageal neoplasms
,
nasopharyngeal carcinoma
,
lung neoplasms
,
sarcoma
,
glioblastoma
,
squamous cell carcinoma of head and neck
,
liver neoplasms
,
uterine cervical neoplasms
,
small cell lung carcinoma
,
ovarian epithelial carcinoma
,
nasopharyngeal neoplasms
,
neuroendocrine tumors
Phenylalanine
glioblastoma
Riboprine
depression
,
drug resistance
,
heat stress disorders
,
mood disorders
,
combat disorders
,
traumatic stress disorders
,
sickle cell anemia
,
inflammation
,
beta-thalassemia
,
thalassemia
,
sickle cell trait
,
heart failure
,
hypertriglyceridemia
,
hiv infections
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
,
wasting syndrome
,
cachexia
,
atrial fibrillation
,
depressive disorder
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use